PLG and liver cancer: There are three commonly used markers in the diagnosis of liver cancer, including (α-fetoprotein (AFP), α-fetoprotein variant (AFP- l3), and abnormal plasminogen (APT)) Li and others (Li et al., 2012) constructed au-coated carbon nanotubes conjugated with antibodies labeled with redox probes, which can be used to detect the markers.